UWPG
Ullmann Wealth Partners Group’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.19M | Buy |
6,423
+61
| +1% | +$11.3K | 0.14% | 61 |
|
2025
Q1 | $1.33M | Buy |
6,362
+167
| +3% | +$35K | 0.18% | 52 |
|
2024
Q4 | $1.1M | Sell |
6,195
-131
| -2% | -$23.3K | 0.14% | 57 |
|
2024
Q3 | $1.25M | Buy |
6,326
+3,301
| +109% | +$652K | 0.16% | 49 |
|
2024
Q2 | $519K | Buy |
3,025
+311
| +11% | +$53.3K | 0.07% | 73 |
|
2024
Q1 | $494K | Buy |
2,714
+447
| +20% | +$81.4K | 0.07% | 72 |
|
2023
Q4 | $351K | Buy |
2,267
+37
| +2% | +$5.74K | 0.06% | 82 |
|
2023
Q3 | $332K | Buy |
2,230
+175
| +9% | +$26.1K | 0.06% | 77 |
|
2023
Q2 | $277K | Buy |
2,055
+760
| +59% | +$102K | 0.06% | 85 |
|
2023
Q1 | $206K | Buy |
+1,295
| New | +$206K | 0.05% | 89 |
|
2017
Q3 | – | Sell |
-413
| Closed | -$29K | – | 50 |
|
2017
Q2 | $29K | Sell |
413
-43
| -9% | -$3.02K | 0.02% | 104 |
|
2017
Q1 | $29K | Buy |
+456
| New | +$29K | 0.02% | 97 |
|